150
Views
0
CrossRef citations to date
0
Altmetric
Eco/Toxicology

Pure and Al-Bi Co-doped SnO2 nanoparticles as bacterial growth inhibitors

ORCID Icon, , ORCID Icon & ORCID Icon
Pages 246-262 | Received 14 Mar 2022, Accepted 08 Aug 2022, Published online: 07 Sep 2022
 

Abstract

The present work is aimed to prepare un-doped and aluminium-bismuth co-doped tin-oxide nanoparticles with 2 weight percentages (each co-dopant 2 wt %) and 4 weight percentages (each 4 wt %) by employing a co-precipitation method. Tetragonal rutile crystal structure of the synthesized materials was confirmed by powder X-ray diffraction, bandgap energy by UV-Vis diffuse reflectance spectral analysis, chemical bonding and the position of O-Sn-O by Fourier transform infrared spectrum and morphology through scanning electron microscopy. The photoluminescence spectrum of synthesized nanoparticles shows emission peaks at 490, 520 and 536 nm. Antibacterial activity of Al-Bi co-doped (4 wt %) SnO2 nanoparticles shows a higher zone of inhibition in the range of 20–36 mm against Staphyllococcus aureus, 25–34 against Bacillus cereus and 30–41 against Escherichia Coli than pure SnO2 nanoparticles. The developed oxygen vacancies due to the addition of dopants increase the generation of reactive oxygen species which increases the inhibition capability of tin-oxide nanoparticles against various bacterial species.

Disclosure statement

Herewith all the authors declare that there is no conflict of interest for the publication of the manuscript.

Data availability statement

By request data can be shared.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.